Leaders must challenge the disability support sector to redesign models so they are aging‑ready and rooted in both ...

Unlike expensive positron emission tomography (PET) scans or invasive lumbar punctures, the new blood test measures the ratio of two proteins, pTau217 and ß-Amyloid 1-42, which are implicated in ...

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.

Martin Kampman, recipient of the Byers Award for outstanding research by faculty members in the middle of their careers, ...

When we think of autism, we might think about younger people. Autism wasn’t formally recognized as a diagnosable condition ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

Isolation, communication difficulties, reduced alertness—hearing impairment or loss is a real challenge in daily life. Over time, it can also become a risk factor for cognitive decline. A team from ...

Is your brain aging faster than your chronological age? New research shows it could raise your risk of death and dementia significantly—and offers promise for early intervention.

Objective: Under the key issue of community aging transformation, it is an inevitable trend to explore in depth to provide effective guidance for the independent travel of the elderly with early ...